Daniel C. Janki - Jul 19, 2021 Form 4 Insider Report for DELTA AIR LINES, INC. (DAL)

Role
EVP & Chief Financial Officer
Signature
/s/ Alan T. Rosselot as attorney-in-fact for Daniel C. Janki
Stock symbol
DAL
Transactions as of
Jul 19, 2021
Transactions value $
$0
Form type
4
Date filed
7/21/2021, 09:15 PM
Previous filing
Jun 17, 2021
Next filing
Feb 3, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction DAL Common Stock Award +117K 117K Jul 19, 2021 Direct F1
transaction DAL Common Stock Award +41.9K +35.89% 159K Jul 19, 2021 Direct F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction DAL Employee Stock Option (right to buy) Award $0 +73.7K $0.00 73.7K Jul 19, 2021 Common Stock 73.7K $38.56 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The shares represent a grant of restricted common stock to Mr. Janki, as approved by the Personnel & Compensation Committee of Delta's Board of Directors (the "Committee"). Subject to the terms of the award, the restrictions on the shares will lapse in three equal installments on July 12, 2022, 2023 and 2024. This grant is exempt from Section 16(b) of the Securities Exchange Act of 1934 under Rule 16b-3(d)(1).
F2 The Committee granted Mr. Janki 41,890 shares of restricted common stock under Delta's 2021 long-term incentive program. The restricted stock will vest pursuant to the terms of the applicable award agreement. This grant is exempt from Section 16(b) of the Securities Exchange Act of 1934 under Rule 16b-3(d)(1).
F3 The Committee granted Mr. Janki an option to purchase 73,730 shares of common stock under Delta's 2021 long-term incentive program. The option will vest and become exercisable in three equal installments beginning on February 1, 2022. This grant is exempt from Section 16(b) of the Securities Exchange Act of 1934 under Rule 16b-3(d)(1).